CCR5 Co-receptor Antagonist [EPC]

1906 reported adverse events

Drugs of this class: MARAVIROC

These side effects are most commonly reported by patients taking drugs of the CCR5 Co-receptor Antagonist [EPC] class:

# Side effect Count
0 DRUG INTERACTION 81
1 VIROLOGIC FAILURE 71
2 ANXIETY 69
3 OFF LABEL USE 65
4 DRUG INEFFECTIVE 64
5 PAIN 62
6 VIRAL MUTATION IDENTIFIED 57
7 NAUSEA 55
8 DRUG RESISTANCE 53
9 PATHOGEN RESISTANCE 52
See all common reactions for CCR5 Co-receptor Antagonist [EPC]

Drugs of the CCR5 Co-receptor Antagonist [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CCR5 RECEPTOR POSITIVE 2 1.0000
1 HIV TROPISM IDENTIFIED 2 1.0000
2 ARTERIOVENOUS GRAFT SITE PSEUDOANEURYSM 2 0.6667
3 LENTICULAR OPERATION 2 0.2857
4 PITUITARY HYPERPLASIA 2 0.2500
5 ANTIVIRAL DRUG LEVEL BELOW THERAPEUTIC 6 0.2143
6 HIV VIRAEMIA 6 0.1333
7 CSF HIV ESCAPE SYNDROME 14 0.1120
8 CONGENITAL VESICOURETERIC REFLUX 7 0.1000
9 CONGENITAL URETERIC ANOMALY 6 0.0984
See all enriched reactions for CCR5 Co-receptor Antagonist [EPC]